One of the leading service providers of face and speaker recognition speaker solutions for security and authentication purposes, KeyLemon, announced the close of a Series A investment. The round was led by Debiopharm Investment, a company of Swisscom Ventures and Debiopharm Group.
Since its inception back in 2008, the company has entrenched itself as a technology leader in the computing space for authentication solutions. The company provides both embedded and cloud based solutions, with partnerships entered into with several blue chip technology companies across a wide range of markets.
The new funds would help provide the necessary resources for KeyLemon to grow and develop its technology and customer solutions. According to KeyLemon CEO Gilles Florey, "The support from our new investors validates our vision of enhancing the authentication process to increase security and make such process easier for our users."
On the other end, Board of Debiopharm Investment Delegate Thierry Mauvernay, "KeyLemon understands the paradox of security: there is no system that can be 100% reliable."
Join the Conversation